Straight answers to the questions that matter

Are you live yet?

No. Rectavion is in development. No entity, no rail chosen yet. This site shows the format we're building toward, not a live offer or a current rate.

Every processor claims to be transparent. Why should I believe you?

Don't take our word for it. Check the pages once they're live: the accept list and the rates will be public before you talk to anyone, so you can verify them yourself instead of trusting a claim.

If you're really going to publish your rates, what's the catch?

No catch. The whole point is letting you check before you commit. Once real rates are set, hiding them would defeat the purpose. Publishing them is the product, not a marketing line.

Will you freeze my money like the last processor did?

If we hold a reserve, your agreement will say why, how much, and when you get it back. A hold you didn't see coming isn't part of the model we're building.

Cards keep cutting off my peptide business: will you?

Since April 2024, the card networks have been actively pushing research-use peptide sellers off entirely (Visa's Integrity Risk Program). We'll tell you straight whether your model can be placed, and on which rail, instead of leaving you to find out the hard way.

Do you actually accept IPTV and SMM panels, or are you just saying that to sound different?

We're building the accept list to include a real answer for both, since no other processor we researched says anything about either one, in either direction. Where it lands depends on which sponsor bank or acquirer we end up working with. We'll publish the real answer, whatever it is, once that's decided, not before.

What rail will you run on: cards, crypto, or both?

Not decided yet. That's one of the open decisions blocking the real build, and we're not going to guess at it publicly before it's real.

Next

More context